StockIQpro
NASDAQ:MBOT

Microbot Medical Inc.

Track all markets on TradingView
Track all markets on TradingView

Microbot Medical Inc. reported net income of −$13.1M in fiscal 2025. Free cash flow was −$13.1M, and the diluted share count rose 192.7%.Summary generated from Microbot Medical Inc.'s SEC filings. Latest annual report filed Mar 26, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−32.4%
Debt / equityn/a
Free cash flow−$13.1M
FCF marginn/a
Share count change+192.7%

Financials

Fiscal years, $M
Item20212022202320242025
Revenuen/an/an/an/an/a
Operating income−11−13−10−12−15
Net income−11−13−11−11−13
Free cash flow−9−12−9−9−13

Recent filings

From SEC EDGAR

Peers

Surgical & medical instruments & apparatus